The ongoing elucidation of SIRT5’s functions and mechanisms may pave the way for novel therapeutic approaches that target metabolic pathways in cancer treatment, potentially improving outcomes for patients with malignancies characterized by dysregulated metabolic processes (20, 21). Here, SIRT5 is linked to cancer.